FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30225911000001100: Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93986501000001118 Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93986601000001119 Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Is a Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has AMP Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has specific active ingredient Cobicistat false Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has specific active ingredient Atazanavir sulfate true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Atazanavir true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has specific active ingredient Cobicistat true Inferred relationship Existential restriction modifier
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Has basis of strength substance Atazanavir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start